• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Permira Funds

Open door symbolizing exit
Pharma

Bavarian Nordic's board chair departs after acquisition fumble

On the heels of a private equity buyout campaign that ultimately fell flat, Bavarian Nordic’s board chair is stepping aside.
Fraiser Kansteiner Nov 13, 2025 4:41pm
Bavarian Nordic

Bavarian Nordic shares plunge as proposed takeover falls through

Nov 6, 2025 1:38pm
Cambrex North Carolina

Permira eyes $4B sale of CDMO Cambrex: FT

Sep 9, 2025 10:36am
MA

As Bavarian Nordic reports sales boost, CEO pushes for takeover

Aug 22, 2025 11:30am
Bavarian Nordic

Bavarian Nordic's largest shareholder objects to $3B buyout bid

Jul 28, 2025 10:31am
Cambrex manufacturing

CDMO Cambrex sells for $2B after aggressive acquisitions

Aug 7, 2019 10:48am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings